Presse medicale (Paris, France : 1983)
Gastrointestinal complications of immune checkpoint Inhibitor therapy.
Franck Carbonnel, Antoine Martin, Lysiane Marthey, Christophe Bellanger, Rita Bou-Farah, Isabelle Boytchev, Raef Abdallah, Aurélien Amiot, Antoine Meyer
Published: 202510.1016/j.lpm.2025.104326
Abstract
Immune checkpoint inhibitors (ICI) have improved the prognosis of several cancers. ICI enhance T-cell activation, and therefore stimulate anti-cancer immunity, but also cause immune related adverse effects (irAE), including those affecting the gastro…
Preview only. Read the full abstract at the source